|
Cardiovascular
Medications |
|
|
Beta-Blockers |
|
|
|
|
Depletions |
|
|
Coenzyme
Q10 |
|
A deficiency of the antioxidant coenzyme Q10 may be associated with chronic
conditions including heart disease and high blood pressure. Symptoms of
deficiency include gingivitis, and weakened immune
function. |
|
|
Melatonin |
|
Reduced levels of melatonin in the body have been associated with sleep
disturbances and jet lag. |
|
|
Editorial Note |
|
|
|
|
Supporting Research |
|
Arendt J, Bojkowski C, Franey C, Wright J, Marks V. Immunoassay of
6-hydroxymelatonin sulfate in human plasma and urine: abolition of the urinary
24-hour rhythm with atenolol. J Clin Endocrin Metab.
1985;60:1166-1173.
Avery D, Lenz M, Landis C. Guidelines for prescribing melatonin. Ann
Med. 1998;30:122-130.
Chan A, Reichmann H, Kogel A, et al. Metabolic changes in patients with
mitochondrial myopathies and effects of coenzyme Q10 therapy. J Neurol.
1998;245(10):681-685.
Folkers K, Morita M, McRee J Jr. The activities of coenzyme Q10 and vitamin
B6 for immune responses. Biochem Biophys Res Commun. 1993;
28(19391):88-92.
Folkers K. Basic chemical research on coenzyme Q-10 and integrated
clinical research on therapy of diseases, in Coenzyme Q, G. Lenaz, ed. John
Wiley & Sons, 1985.
Kamikawa T, Kobayashi A, Yamashita T, et al. Effects of coenzyme Q10 on
exercise tolerance in chronic stable angina pectoris. Am J Cardiol.
1985;56(4):247-251.
Kishi H, Kishi T, Folkers K. Bioenergetics in clinical medicine. III.
Inhibition of coenzyme Q10-enzymes by clinically used anti-hypertensive drugs.
Res Commun Chem Pathol Pharmacol. 1975;12(3):533-540.
Munkholm H, Hansen HH, Rasmussen K. Coenzyme Q10 treatment in serious heart
failure. Biofactors. 1999;9(2-4):285-289.
Nakamura R, Littarru GP, Folkers R, et al. Study of CoQ10-enzymes in gingiva
from patients with periodontal disease and evidence for a deficiency of coenzyme
Q10. Proc Natl Acad SciUSA. 1974;71(4):1456-1460.
Rommell T, Demisch L. Influence of chronic beta-adrenoreceptor blocker
treatment on melatonin secretion and sleep quality in patients with essential
hypertension. J Neural Transm [Gen Sect]. 1994;95:39-48.
Singh RB, Niaz MA, Rastogi SS, et al. Effect of hydrosoluble coenzyme Q10 on
blood pressure and insulin resistance in hypertensive patients with coronary
heart disease. J Hum Hypertens. 1999;13(3):203-208.
Singh RB, Wander GS, Rastogi A, et al. Randomized, double-blind
placebo-controlled trial of coenzyme Q10 in patients with acute myocardial
infarction. Cardiovasc Drugs Ther.
1998;12(4):347-353. |
|
Review Date:
October 2000 |
Reviewed By:
All depletions monographs have been reviewed by a
team of experts including
Derrick M. DeSilva, Jr., MD, Raritan Bay Medical Center, Perth Amboy, NJ;
Jacqueline A. Hart, MD, Department of Internal Medicine, Newton-Wellesley
Hospital, Harvard University and Senior Medical Editor, A.D.A.M., Inc., Boston,
MA; John Hinze, PharmD, NMD, Woodbine, IA; Ruth Marlin, MD, Medical Director and
Director of Medical Education, Preventive Medicine Research Institute,
Sausalito, CA; Brian T Sanderoff, PD, BS in Pharmacy, Clinical Assistant
Professor, University of Maryland School of Pharmacy; President, Your
Prescription for Health, Owings Mills, MD; Leonard Wisneski, MD, FACP, George
Washington University, Rockville, MD; Ira Zunin, MD, MPH, MBA, President and
Chairman, Hawaii State Consortium for Integrative Medicine, Honolulu,
HI.
|
|
|
|
|